U.S. stocks were higher, with the Dow Jones index gaining around 400 points on Monday.
Shares of Terns Pharmaceuticals, Inc. (NASDAQ:TERN) rose sharply in today's pre-market trading session.
The company announced a top-line data from its Phase 1 randomized, double-blind, placebo-controlled single and multiple-ascending dose trial to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of TERN-601 dosed once-daily in healthy adults with obesity or overweight.
Terns Pharmaceuticals shares jumped 20.2% to $9.38 on Monday.
Here are some other big stocks recording gains in today's session.
Now Read This:
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
